MD Anderson receives over $10 million from Break Through Cancer to support collaborative research with leading cancer centers
The University of Texas MD Anderson Cancer Center was awarded more than $10 million in grants to support collaborative research teams working to advance novel interception and treatment strategies that will improve outcomes for several cancer types with the greatest unmet need, including pancreatic cancer, ovarian cancer and glioblastoma (GBM).
Funded by Break Through Cancer, this work is part of $50 million in grants being made...
Vitamin E can boost immunotherapy responses by reinvigorating dendritic cells
Combining a retrospective analysis of clinical records with in-depth laboratory studies, researchers at The University of Texas MD Anderson...
New platform optimizes selection of combination cancer therapies
Abstract: LB119
Researchers at The University of Texas MD Anderson Cancer Center have developed a new bioinformatics platform that...
MD Anderson Research Highlights: AACR 2022 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. This special edition features presentations by MD Anderson researchers at the American Association for Cancer Research (AACR) Annual Meeting 2022, including early-stage clinical trials on immunotherapy and targeted therapies plus laboratory studies to improve...
